Provectus Announces Poster Presentation On PV-10 At European Society Of Medical Oncology 2016 Congress Now Available Online
KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Biopharmaceuticals, Inc. (NYSE MKT: PVCT, www.provectusbio.com), a clinical-stage oncology and dermatology biopharmaceutical company ("Provectus" or the "Company”), today announced that the poster presented at the European Society of Medical Oncology 2016 Congress is now available online.